Progression in the severity of aortic stenosis according to race among those with advanced chronic kidney disease

Aamir Husain1, Sameer Arora2,3, Paula D Strassle3

  • 1Division of Internal Medicine, University of Illinois at Chicago, Chicago, IL, USA.

Insights

White patients with advanced chronic kidney disease (CKD) may experience faster aortic stenosis (AS) progression than black patients. This initial study highlights potential racial differences in AS progression within this vulnerable population.

Area of Science:

  • Cardiology
  • Nephrology
  • Clinical Research

Background:

  • Aortic stenosis (AS) is more prevalent in patients with advanced chronic kidney disease (CKD).
  • Existing research lacks comparisons of AS progression between white and black patients with advanced CKD.

Purpose of the Study:

  • To investigate and compare the progression of aortic stenosis (AS) in white versus black patients with advanced chronic kidney disease (CKD).
  • To analyze racial differences in AS progression rates within a pre-operative kidney transplant evaluation cohort.

Main Methods:

  • Retrospective analysis of advanced CKD (stage IV-V) patients evaluated for kidney transplantation between 2006-2016.
  • AS progression assessed using serial transthoracic echocardiograms, excluding data post-transplantation or aortic valve replacement.
  • Comparison of changes in mean gradient, aortic valve area (AVA), and transvalvular velocity between white and black patients using mixed-effects models.

Main Results:

  • 140 patients (34% white, 66% black) had baseline or developed AS.
  • White patients showed a trend towards faster progression in mean gradient (1.90 vs. 1.46 mmHg/year), AVA (-0.10 vs. -0.08 m²/year), and transvalvular velocity (0.11 vs. 0.07 m/s/year) compared to black patients.
  • No significant baseline differences in AS severity or age were observed between racial groups.

Conclusions:

  • White patients with advanced CKD may exhibit more rapid progression of aortic stenosis compared to black patients.
  • This study is the first to examine racial disparities in AS progression within an advanced CKD population.
  • Larger sample sizes are required to validate these preliminary findings and confirm racial differences in AS progression.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
481
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
276
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
480
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
215
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
441
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
120